Cancer drug resistance: redox resetting renders a way - sprookjes - yvandenbroek - TriplyDB

Cancer drug resistance: redox resetting renders a way

Cancer drug resistance: redox resetting renders a way

http://www.wikidata.org/entity/Q26750753

about

sameAs

ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies Cancer: An Oxidative Crosstalk between Solid Tumor Cells and Cancer Associated Fibroblasts Acid sphingomyelinase as target of Lycium Chinense: promising new action for cell health Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.Regulation of multidrug resistance by microRNAs in anti-cancer therapy Oxidative Stress, Nrf2, and Epigenetic Modification Contribute to Anticancer Drug Resistance.The pharmacogenomics of drug resistance to protein kinase inhibitors.Oxidative stress management in the hair follicle: Could targeting NRF2 counter age-related hair disorders and beyond?The orally active pterocarpanquinone LQB-118 exhibits cytotoxicity in prostate cancer cell and tumor models through cellular redox stress.Thermoresponsive Supramolecular Chemotherapy by "V"-Shaped Armed β-Cyclodextrin Star Polymer to Overcome Drug Resistance.Codelivery for Paclitaxel and Bcl-2 Conversion Gene by PHB-PDMAEMA Amphiphilic Cationic Copolymer for Effective Drug Resistant Cancer Therapy.Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses Cisplatin Resistance in Lung Cancer Cells via the Redox System.Redox Paradox: A novel approach to therapeutics-resistant cancer.The oxidoreductase p66Shc acts as tumor suppressor in BRAFV600E-transformed cells.Expression of genes and proteins of multidrug resistance in gastric cancer cells treated with resveratrol.Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance Peroxiredoxin II Regulates Cancer Stem Cells and Stemness-Associated Properties of Cancers

P2860

Q26747496-D4FD61C9-B435-41B7-A2EC-0E297DF2A5A7 Q28078990-3B9E09C6-E3D3-4B49-931F-D6C3171F8D02 Q28821632-883ABCB2-26B7-4077-ADC5-169647E73F11 Q33661710-7AE02004-DDFE-49E4-A1A0-819E1F0472BC Q37587311-BADB0DE5-506C-4BDA-ADFC-D33E5624D358 Q37606602-18ED2A1A-DE97-4608-B454-2E80AC5E129D Q38952751-79C88785-B10E-419F-AD21-B7592FF8D51F Q39420496-E2422598-ED73-471A-A1DB-A00E5D45030D Q46268309-E7315765-055B-4843-AFCF-1AF6AC0CF4EF Q47216688-88A36DC0-7185-4EB3-9EF2-F528C05FFFE4 Q47917079-AEE47EBC-7878-4AD2-947F-E3261D79796D Q49441931-4F20B12B-AE22-4DED-8459-D397CC35E333 Q50082485-888CE09A-632D-41B7-A89E-BF61B1549617 Q53697878-32342A97-25CF-4223-95F7-2DB55C777CFF Q54094783-334CA631-91E4-4D59-9994-A2961E8A55B6 Q57257740-54B4B3D0-EB4F-48BC-957F-DAE212884C05 Q58766557-3342F762-4158-4396-973D-381C1C89DDAE

P2860

Cancer drug resistance: redox resetting renders a way

http://www.wikidata.org/entity/Q26750753

description

2016 nî lūn-bûn

@nan

2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Cancer drug resistance: redox resetting renders a way

@ast

Cancer drug resistance: redox resetting renders a way

@en

Cancer drug resistance: redox resetting renders a way

@nl

type

label

Cancer drug resistance: redox resetting renders a way

@ast

Cancer drug resistance: redox resetting renders a way

@en

Cancer drug resistance: redox resetting renders a way

@nl

prefLabel

Cancer drug resistance: redox resetting renders a way

@ast

Cancer drug resistance: redox resetting renders a way

@en

Cancer drug resistance: redox resetting renders a way

@nl

P1433

Q26750753-EE94ED96-86E0-441D-BBEB-0EF20D96D0B1

P1476

Q26750753-07A60B83-6EE5-42D3-8970-12CE754686DA

P2093

Q26750753-04130271-22FF-4B91-AA0C-E185543BF60D

Q26750753-957842F9-0715-44CA-97B0-594CA77EA4B9

Q26750753-A97CDD73-26CA-4384-A350-0C615C7114DA

Q26750753-C81246D0-879D-4CA6-B3CF-4EFE3BB874FC

Q26750753-D12A9BC6-6831-479B-B597-F5D4F335E2B3

Q26750753-F64BCC17-1C10-40CA-BEFF-356073DA950E

Q26750753-FCA68D25-3FE0-4EA8-84E9-0446809D4D7B

P275

Q26750753-8C10A145-8A22-4873-B4E8-7F4FE4946896

P2860

Q26750753-01EC8091-AC07-4835-AF61-66A968F4A64D

Q26750753-0450A586-CE55-44B7-BAF8-9B878CCD16D8

Q26750753-05319FEB-97B4-41E6-ACD3-7B955F2D70AE

Q26750753-061F2EE0-8B2B-490C-B8EE-CE794B081708

Q26750753-08F8EB57-991A-41F3-A83B-754814E02CEA

Q26750753-093597C0-CBD5-401E-B29A-33C485F5846C

Q26750753-09DD2D18-87FE-469E-AC27-4AF5305C958F

Q26750753-0AC9A662-7BDB-425D-952D-D0E33CB6B1BD

Q26750753-0C1DE6BC-FDA0-4CED-9174-BF3D2ACEEB7B

Q26750753-0E7CC91E-6CDD-4CCA-AFAB-B554AE14C384

P304

Q26750753-7F3843B2-068E-4715-AEB4-ACEBB011744D

P31

Q26750753-6EB3B4D9-85E6-4034-905D-321BF47B289E

P3181

Q26750753-6A6CDE60-376A-48A1-B0BD-D47C95E3EF9A

P356

Q26750753-27DD466D-53DA-4F3D-981C-AE84074D66F0

P407

Q26750753-420B6700-5C8A-47BD-A485-2FD473B8FAF2

P433

Q26750753-63F5DFC6-1C82-40FA-BD43-12F6D5909253

P478

Q26750753-DB42398B-5D57-48BC-9F79-324A8D7C5380

P50

Q26750753-BEA0CA55-952A-48E7-9955-36692AA9ACC1

P5008

Q26750753-CE8018D2-03FA-49DC-B748-854C19AD6B17

P577

Q26750753-213A8C0C-26F8-427E-B101-425D07F2D6A3

P5875

Q26750753-42CAC11E-6E35-404B-B1F5-23B55173AC8E

P698

Q26750753-B9F19DB0-2174-4B6C-AF6C-AAF111188CD4

P921

Q26750753-21906E55-6321-48B6-80CE-7CC645C9970B

Q26750753-ECEF74CC-CF1A-4140-B90D-AAB1982960FA

P932

Q26750753-E3869426-CDF4-4FBD-BB00-1FF700F3F1BA

P3181

P356

ONCOTARGET.8600

P1433

P1476

Cancer drug resistance: redox resetting renders a way

@en

P2093

Canhua Huang

http://www.w3.org/2001/XMLSchema#string

Edouard C Nice

http://www.w3.org/2001/XMLSchema#string

Haiyuan Zhang

http://www.w3.org/2001/XMLSchema#string

Li Zhou

http://www.w3.org/2001/XMLSchema#string

Na Xie

http://www.w3.org/2001/XMLSchema#string

Qifu Li

http://www.w3.org/2001/XMLSchema#string

Yunlong Lei

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

Hallmarks of Cancer: The Next Generation

The Fas death signaling pathway connecting reactive oxygen species generation and FLICE inhibitory protein down-regulation

Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands

Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals

ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair

Stimulation of NEIL2-mediated oxidized base excision repair via YB-1 interaction during oxidative stress

A new fork for clinical application: targeting forkhead transcription factors in cancer

Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4

Redox regulation of human OGG1 activity in response to cellular oxidative stress

Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP

P304

42740-42761

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

579769

http://www.w3.org/2001/XMLSchema#string

P356

10.18632/ONCOTARGET.8600

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

300080722

http://www.w3.org/2001/XMLSchema#string

P698

27057637

http://www.w3.org/2001/XMLSchema#string

P921

physiological phenomena

P932

5173169

http://www.w3.org/2001/XMLSchema#string